Literature DB >> 11459087

Expression and significance of vascular permeability factor in tumour infiltrating lymphocytes of brain metastases.

J Vaquero1, M Zurita, S Oya.   

Abstract

BACKGROUND: Recently, vasogenic edema has been related to the expression of vascular permeability factor (VPF) by tumour cells in brain metastases. On the other hand, expression of VPF has been reported in inflammatory cells. Keeping in mind the current presence of tumour-infiltrating lymphocytes (TIL) in brain metastases, our objective is to study the expression and significance of VPF in TIL-cells from specimens of brain metastases.
METHOD: Tumour samples from 16 brain metastases associated with peritumoural edema were immunohistochemically studied for demonstration of VPF. The degree of VPF-expression by tumour cells and TIL was determined, and correlated with the degree of peritumoural edema.
FINDINGS: Our present results show that, independently of the VPF-positivity expressed by the tumour cells, VPF-expression is a constant finding in TIL-cells of brain metastases, and correlated with the amount of peritumoural edema.
INTERPRETATION: Our present findings suggest a role for TIL-cells in the development of vasogenic edema associated with brain metastases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11459087     DOI: 10.1007/s007010170121

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  2 in total

1.  Correlation Analysis between Retention of Gd-DTPA in the Cystic Area of Brain Metastasis and MRI Signs.

Authors:  Jili Wang; Shanshan Qu; Qinyan Xu; Zhaofeng Jin; Tian Li; Shuxian Zhang; Xihe Sun
Journal:  J Oncol       Date:  2022-06-18       Impact factor: 4.501

Review 2.  Delayed diffuse cerebellar swelling after resection of medulloblastoma: case report and review of literature.

Authors:  Ashley L B Raghu; Jothy Kandasamy; Mark Brougham; Pasquale Gallo; Drahus Sokol; Mark A Hughes
Journal:  Childs Nerv Syst       Date:  2017-06-29       Impact factor: 1.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.